# Unveiling Replication Timing-Dependent Mutational Biases: Mechanistic Insights from Gene Knockouts and Genotoxins Exposures

**Authors:** Hadas Gross-Samuels, Amnon Koren, Itamar Simon

PMC · DOI: 10.3390/ijms26157307 · International Journal of Molecular Sciences · 2025-07-29

## TL;DR

This study explores how DNA replication timing affects mutation rates and identifies genes and compounds that influence mutations differently depending on replication timing.

## Contribution

The study systematically identifies DNA repair genes and mutagenic compounds with replication timing-specific effects on genomic instability.

## Key findings

- 14 genes involved in DNA repair pathways show differential effects in early- or late-replicating regions.
- 19 mutagenic compounds exhibit replication timing-specific effects on mutation rates.
- Replication timing is a critical modulator of mutagenesis and genomic instability.

## Abstract

Replication timing (RT), the temporal order of DNA replication during S phase, influences regional mutation rates, yet the mechanistic basis for RT-associated mutagenesis remains incompletely defined. To identify drivers of RT-dependent mutation biases, we analyzed whole-genome sequencing data from cells with disruptions in DNA replication/repair genes or exposed to mutagenic compounds. Mutation distributions between early- and late-replicating regions were compared using bootstrapping and statistical modeling. We identified 14 genes that exhibit differential effects in early- or late-replicating regions, encompassing multiple DNA repair pathways, including mismatch repair (MLH1, MSH2, MSH6, PMS1, and PMS2), trans-lesion DNA synthesis (REV1) and double-strand break repair (DCLRE1A and PRKDC), DNA polymerases (POLB, POLE3, and POLE4), and other genes central to genomic instability (PARP1 and TP53). Similar analyses of mutagenic compounds revealed 19 compounds with differential effects on replication timing. These results establish replication timing as a critical modulator of mutagenesis, with distinct DNA repair pathways and exogenous agents exhibiting replication timing-specific effects on genomic instability. Our systematic bioinformatics approach identifies new DNA repair genes and mutagens that exhibit differential activity during the S phase. These findings pave the way for further investigation of factors that contribute to genome instability during cancer transformation.

## Linked entities

- **Genes:** MLH1 (mutL homolog 1) [NCBI Gene 4292], MSH2 (mutS homolog 2) [NCBI Gene 4436], MSH6 (mutS homolog 6) [NCBI Gene 2956], PMS1 (PMS1 homolog 1, mismatch repair system component) [NCBI Gene 5378], PMS2 (PMS1 homolog 2, mismatch repair system component) [NCBI Gene 5395], REV1 (REV1 DNA directed polymerase) [NCBI Gene 51455], DCLRE1A (DNA cross-link repair 1A) [NCBI Gene 9937], PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591], POLB (DNA polymerase beta) [NCBI Gene 5423], POLE3 (DNA polymerase epsilon 3, accessory subunit) [NCBI Gene 54107], POLE4 (DNA polymerase epsilon 4, accessory subunit) [NCBI Gene 56655], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142], TP53 (tumor protein p53) [NCBI Gene 7157]

## Full-text entities

- **Genes:** POLE4 (DNA polymerase epsilon 4, accessory subunit) [NCBI Gene 56655] {aka YHHQ1, p12}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, MSH2 (mutS homolog 2) [NCBI Gene 4436] {aka COCA1, FCC1, HNPCC, HNPCC1, LCFS2, LYNCH1}, PMS1 (PMS1 homolog 1, mismatch repair system component) [NCBI Gene 5378] {aka HNPCC3, MLH2, PMSL1, hPMS1}, REV1 (REV1 DNA directed polymerase) [NCBI Gene 51455] {aka AIBP80, REV1L}, PMS2 (PMS1 homolog 2, mismatch repair system component) [NCBI Gene 5395] {aka HNPCC4, LYNCH4, MLH4, MMRCS4, PMS-2, PMSL2}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, POLB (DNA polymerase beta) [NCBI Gene 5423], POLE3 (DNA polymerase epsilon 3, accessory subunit) [NCBI Gene 54107] {aka CHARAC17, CHRAC17, CHRAC2, YBL1, p17}, MSH6 (mutS homolog 6) [NCBI Gene 2956] {aka GTBP, GTMBP, HNPCC5, HSAP, LYNCH5, MMRCS3}, DCLRE1A (DNA cross-link repair 1A) [NCBI Gene 9937] {aka PSO2, SNM1, SNM1A}, PRKDC (protein kinase, DNA-activated, catalytic subunit) [NCBI Gene 5591] {aka DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC}, MLH1 (mutL homolog 1) [NCBI Gene 4292] {aka COCA2, FCC2, HNPCC, HNPCC2, LYNCH2, MLH-1}
- **Diseases:** cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12347494/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12347494/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12347494/full.md

---
Source: https://tomesphere.com/paper/PMC12347494